The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis

BACKGROUND: The prognosis of gastric cancer (GC) patients with peritoneal metastasis (PM) is extremely poor. We developed a new promising regimen combining intraperitoneal (i.p.) paclitaxel (PTX) with systemic PTX and S-1 chemotherapy for GC patients with PM. However, the value of conversion surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinkai, Masayuki, Imano, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660049/
https://www.ncbi.nlm.nih.gov/pubmed/36388679
http://dx.doi.org/10.21037/jgo-21-431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660049/
https://www.ncbi.nlm.nih.gov/pubmed/36388679
http://dx.doi.org/10.21037/jgo-21-431

Ejemplares similares